Small Extracellular Vesicles from Menstrual Blood-Derived Mesenchymal Stem Cells as a Novel Therapeutic Impetus in Regenerative Medicine

The document discussed the potential of small extracellular vesicles (EVs) derived from menstrual blood-derived mesenchymal stem cells (MenSCs) in regenerative medicine. Although research on MenSC-derived small EVs was in its early stages compared to other mesenchymal stem cell sources, the study highlighted their promising therapeutic effects in various conditions, including fulminant hepatic failure, myocardial infarction, pulmonary fibrosis, prostate cancer, cutaneous wounds, type-1 diabetes mellitus, and aged fertility. The document emphasized the rapid advancements in understanding the therapeutic potential of MenSC EVs and proposed new areas for research to address existing challenges, suggesting that MenSC EV-based treatments could become a novel strategy in regenerative medicine.